These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 19720212

  • 1. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC, da Rosa MA, Lopes VS, e Ferreira EF, Vieira LQ, Sobrinho AP.
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [Abstract] [Full Text] [Related]

  • 2. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T, Galatowicz G, Bunce C, Calder V, Lynn WA, Lightman S.
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [Abstract] [Full Text] [Related]

  • 3. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 4. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
    Tappuni AR, Fleming GJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
    Siddiqui U, Bini EJ, Chandarana K, Leong J, Ramsetty S, Schiliro D, Poles M.
    J Clin Gastroenterol; 2007 Dec; 41(5):484-90. PubMed ID: 17450031
    [Abstract] [Full Text] [Related]

  • 6. Implant-prosthetic treatment in HIV-infected patients receiving highly active antiretroviral therapy: report of cases.
    Strietzel FP, Rothe S, Reichart PA, Schmidt-Westhausen AM.
    Int J Oral Maxillofac Implants; 2006 Dec; 21(6):951-6. PubMed ID: 17190306
    [Abstract] [Full Text] [Related]

  • 7. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A, Burgess P, Judd F, Grech P, Komiti A, Hoy J, Lloyd JH, Gibbie T, Street A.
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [Abstract] [Full Text] [Related]

  • 8. Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children.
    Miziara ID, Weber R.
    J Oral Pathol Med; 2008 Feb; 37(2):99-106. PubMed ID: 18197855
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil.
    Moura MD, Grossmann Sde M, Fonseca LM, Senna MI, Mesquita RA.
    J Oral Pathol Med; 2006 Jul; 35(6):321-6. PubMed ID: 16762011
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
    Shah SU, Kerkar SP, Pazare AR.
    Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
    [Abstract] [Full Text] [Related]

  • 11. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
    Voirin N, Routy JP, Smith D, Baratin D, Trépo C, Cotte L, Touraine JL, Livrozet JM, Cooper DA, Ritter J, André P, Vanhems P.
    HIV Med; 2008 Jul; 9(6):440-4. PubMed ID: 18705761
    [Abstract] [Full Text] [Related]

  • 12. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML, Jackson GL, Smith R, Wilson KH.
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [Abstract] [Full Text] [Related]

  • 13. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P, Fassino S, Lavagnino L, Orofino G, Morosini P, Picardi A.
    Psychother Psychosom; 2009 Apr; 78(4):254-7. PubMed ID: 19468260
    [Abstract] [Full Text] [Related]

  • 14. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients.
    Campo J, Cano J, del Romero J, Hernando V, Rodríguez C, Bascones A.
    Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440
    [Abstract] [Full Text] [Related]

  • 15. Success of root canal therapy in HIV-positive patients.
    Shetty K, Garcia J, Leigh J.
    Gen Dent; 2006 Jan; 54(6):397-402. PubMed ID: 17134076
    [Abstract] [Full Text] [Related]

  • 16. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [Abstract] [Full Text] [Related]

  • 17. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB, Toutous-Trellu L, Gayet-Ageron A, Baumann M, Cathomas G, Steffen I, Erb P, Mueller NJ, Furrer H, Cavassini M, Vernazza P, Hirsch HH, Bernasconi E, Hirschel B, Swiss HIV Cohort Study.
    AIDS; 2008 May 31; 22(9):1019-28. PubMed ID: 18520345
    [Abstract] [Full Text] [Related]

  • 18. Periodontal conditions and distribution of Prevotella intermedia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in HIV-infected patients undergoing anti-retroviral therapy and in an HIV-seronegative group of the Venezuelan population.
    Brito A, Escalona LA, Correnti M, Perrone M, Bravo IM, Tovar V.
    Acta Odontol Latinoam; 2008 May 31; 21(1):89-96. PubMed ID: 18841752
    [Abstract] [Full Text] [Related]

  • 19. Current oral manifestations of HIV infection.
    Navazesh M.
    J Calif Dent Assoc; 2001 Feb 31; 29(2):137-41. PubMed ID: 11324113
    [Abstract] [Full Text] [Related]

  • 20. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
    Walenda C, Kouakoussui A, Rouet F, Wemin L, Anaky MF, Msellati P.
    J Trop Pediatr; 2009 Jun 31; 55(3):170-6. PubMed ID: 19066169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.